150 related articles for article (PubMed ID: 28715140)
1. The natural history of thin melanoma and the utility of sentinel lymph node biopsy.
Durham AB; Schwartz JL; Lowe L; Zhao L; Johnson AG; Harms KL; Bichakjian CK; Orsini AP; McLean SA; Bradford CR; Cohen MS; Johnson TM; Sabel MS; Wong SL
J Surg Oncol; 2017 Dec; 116(8):1185-1192. PubMed ID: 28715140
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
3. Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.
Rubinstein JC; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Cancer Med; 2016 Oct; 5(10):2832-2840. PubMed ID: 27671840
[TBL] [Abstract][Full Text] [Related]
4. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
9. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
10. Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma.
Sinnamon AJ; Neuwirth MG; Bartlett EK; Zaheer S; Etherington MS; Xu X; Elder DE; Czerniecki BJ; Fraker DL; Karakousis GC
J Surg Oncol; 2017 Dec; 116(7):848-855. PubMed ID: 28650537
[TBL] [Abstract][Full Text] [Related]
11. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
[TBL] [Abstract][Full Text] [Related]
12. Twelve years' experience of sentinel lymph node biopsy for melanoma at a rural New Zealand hospital.
Sakowska MM; Smith N; Coutts RJ
N Z Med J; 2014 Jun; 127(1395):12-22. PubMed ID: 24929689
[TBL] [Abstract][Full Text] [Related]
13. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
14. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
15. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ
Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients.
Savar A; Ross MI; Prieto VG; Ivan D; Kim S; Esmaeli B
Ophthalmology; 2009 Nov; 116(11):2217-23. PubMed ID: 19766318
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy for ocular adnexal melanoma.
Pfeiffer ML; Ozgur OK; Myers JN; Peng A; Ning J; Zafereo ME; Thakar S; Thuro B; Prieto VG; Ross MI; Esmaeli B
Acta Ophthalmol; 2017 Jun; 95(4):e323-e328. PubMed ID: 27775232
[TBL] [Abstract][Full Text] [Related]
19. A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas.
Cooper C; Wayne JD; Damstetter EM; Martini M; Gordon J; Guitart J; West DP; Nardone B; Rademaker A; Gerami P
J Am Acad Dermatol; 2013 Nov; 69(5):693-699. PubMed ID: 23978604
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in melanoma: final results of MSLT-I.
Durham AB; Wong SL
Future Oncol; 2014 May; 10(7):1121-3. PubMed ID: 24947251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
